Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Total 13F shares
-
5,771
-
Share change
-
-21,416
-
Total reported value
-
$318,213
-
Price per share
-
$55.14
-
Number of holders
-
1
-
Value change
-
-$1,243,658
-
Number of buys
-
1
-
Number of sells
-
1
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q4 2023
As of 31 Dec 2023,
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
5,771 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Rubric Capital Management LP, Deep Track Capital, LP, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Global Alpha Capital Management Ltd., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Ranger Investment Management, L.P., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
180
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.